| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Sigilon Therapeutics, Inc. | | Disposition | Stock Option (Right to Buy) | 683 | $6.64 | $4.5k | | 08/11/2023 |
| 08/11/2023 | Sigilon Therapeutics, Inc. | | Disposition | Stock Option (Right to Buy) | 683 | $5.00 | $3.4k | | 08/11/2023 |
| 08/11/2023 | Sigilon Therapeutics, Inc. | | Disposition | Stock Option (Right to Buy) | 3.8k | $7.51 | $28.2k | | 08/11/2023 |
| 12/05/2022 | Aridis Pharmaceuticals, Inc. | ARDS | Grant | Restricted Stock Units | 10k | $0.00 | $0 | | 12/05/2022 |
| 05/26/2022 | Sigilon Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 8.9k | $0.76 | $6.8k | | 05/26/2022 |
| 10/04/2021 | Aridis Pharmaceuticals, Inc. | ARDS | Grant | Stock Options | 7k | $3.60 | $25.2k | | 10/04/2021 |
| 07/01/2021 | Sigilon Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 6.8k | $0.57 | $3.8k | | 07/01/2021 |
| 07/01/2021 | Sigilon Therapeutics, Inc. | | Sale | Common Stock | 6.8k | $10.36 | $69.9k | | 07/01/2021 |
| 06/24/2021 | Sigilon Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 8.9k | $9.97 | $88.6k | | 06/24/2021 |
| 12/03/2020 | Sigilon Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 8.9k | $18.00 | $160k | | 12/03/2020 |
| 08/13/2019 | Aridis Pharmaceuticals, Inc. | ARDS | Grant | Stock Options | 35k | $8.39 | $293.6k | | 08/13/2019 |
| 06/14/2018 | Diffusion Pharmaceuticals Inc. | DFFN | Grant | Stock Option (Right to Buy) | 40k | $0.54 | $21.6k | | 06/14/2018 |
| 01/02/2018 | Diffusion Pharmaceuticals Inc. | DFFN | Grant | Stock Option (Right to Buy) | 25k | $1.18 | $29.5k | | 01/02/2018 |